Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-25-053619
Filing Date
2025-05-28
Accepted
2025-05-28 17:01:17
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 tm2515975-1_s3.htm S-3 435801
2 EXHIBIT 4.5 tm2515975d2_ex4-5.htm EX-4.5 415634
3 EXHIBIT 4.6 tm2515975d2_ex4-6.htm EX-4.6 436155
4 EXHIBIT 5.1 tm2515975d2_ex5-1.htm EX-5.1 25632
5 EXHIBIT 23.1 tm2515975d2_ex23-1.htm EX-23.1 2266
6 EX-FILING FEES tm2515975d2_ex-filingfees.htm EX-FILING FEES 29718
7 GRAPHIC lg_gaintherapeutics-4c.jpg GRAPHIC 14486
8 GRAPHIC fc_pipeline-4c.jpg GRAPHIC 42846
9 GRAPHIC tm2515975d2_ex5-1img001.jpg GRAPHIC 5479
10 GRAPHIC tm2515975d2_ex5-1img002.jpg GRAPHIC 18913
11 GRAPHIC tm2515975d2_ex5-1img003.jpg GRAPHIC 11038
  Complete submission text file 0001104659-25-053619.txt   1474465
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

EIN.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-287622 | Film No.: 25996221
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)